Evidence map›Paper›PMID 42073622›Full record

ArticleCancers2026

Sociodemographic Factors and Treatment Patterns Associated with Overall Survival in Splenic Marginal Zone Lymphoma: A Nationwide Retrospective Cohort Study (2000-2022).

Manas Pustake, Oboseh Ogedegbe, Atulya Aman Khosla, Sakditad Saowapa, Mohammad Arfat Ganiyani, Avi Harisingani, Nishant Tiwari, Stevenson Ongsyping, Jesus Gomez

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Manas PustakeDepartment of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.ORCID 0000-0002-3566-0389
Oboseh OgedegbeDepartment of Internal Medicine, Trinity Health Ann Arbor Hospital, Ypsilanti, MI 48197, USA.ORCID 0009-0000-7213-2166
Atulya Aman KhoslaDepartment of Internal Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, MI 48073, USA.ORCID 0000-0002-8373-4290
Sakditad SaowapaDepartment of Hematology and Oncology, University of Iowa Health Care Medical Center, Iowa City, IA 52242, USA.ORCID 0000-0002-4978-8674
Mohammad Arfat GaniyaniDepartment of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA.ORCID 0000-0002-6202-0117
Avi HarisinganiDepartment of Internal Medicine, Loyola MacNeal Hospital, Berwyn, IL 60402, USA.
Nishant TiwariDepartment of Hematology and Oncology, Stephenson Cancer Center, University of Oklahoma Health, Oklahoma City, OK 73104, USA.
Stevenson OngsypingDepartment of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.
Jesus GomezDepartment of Hematology and Oncology, University Medical Center of El Paso, El Paso, TX 79905, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

competing risksCox proportional hazardsHispanic ethnicitymarital statusoverall survivalpopulation-based studySEERsociodemographic factorssplenic marginal zone lymphomasystemic antineoplastic therapy

Identifiers

PMID42073622
PMCPMC13114261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.